A research filter, not a predictor — not financial advice. Grades rank growth stocks on evidence-based quality signals from end-of-day data; they are not buy/sell calls or price forecasts. Always do your own research.

OmniAb, Inc. OABI

Promising (early) broader-coverage candidate · OmniAb, Inc. is an American biotechnology firm focused on pioneering therapeutic antibody discovery. The company provides a sophisticated platform that allows its industry partners

On FrontierLab's discovery record since 2026-08-07 (2 weeks ago) — when this name first surfaced. (distinct from the snapshot date below)

Auto-graded broader coverage — sourced by an automated screen and graded on default bands, not the sector-calibrated bands the curated screener uses. A "Promising (early)" here is NOT the same bar as a curated grade; these are auto-screened candidates for your own research, shown as of their surface date (2026-08-08), not the curated Frontier signal.

⚡ Surfaced on a price move — momentum is where to look, not a buy signal. The move that surfaced this name does not make it a good entry.

⚠ Pump risk: parabolic/spike characteristics detected in the screen flags. Treat any positive grade with extra skepticism.

Key quality signals

Revenue growth (YoY)	66.9%
Gross margin	50.5%
Gross profits / assets	0.07
Rule of 40	-58.9
Net margin	-125.8%
Cash runway (months)	27.6
PEG	—
Price / sales	9.5

Quality checklist

✓ Revenue growth — 66.9% (pass ≥ 20%)
✓ Capital efficiency
~ Gross margin — 50.5% (pass ≥ 60%)
✗ Gross-margin trend — -48.4 (pass ≥ 2)
✓ Share dilution — 21.3%

Fundamentals — snapshot as of 2026-08-08

Stage	Early
Share issuance (YoY)	21.3% · heavy issuance
Moat	—
TAM	—
P/E (trailing)	—
EPS (trailing)	$-0.36
Burn multiple	0.6
Gross-margin trend (pts)	-48.4
Cash / assets	0.18
Net debt / EBITDA	—
Statements as of	Q2 FY2026 · filed 2026-08-06

Momentum context — a snapshot from 2026-08-08, not current

Price at surface	$3.08 (as of 2026-08-08)
52-week range	$1.3 – $3.12
% off 52-wk high	-1.3%
RSI (14)	80
Relative volume	5×

Risk flags

Burning cash — operating margin is negative.Heavy dilution (~21%/yr) — top-decile share issuers have historically underperformed.Parabolic one-day spike (+38%) in the last month — extreme single-day moves tend to mean-revert.Volume 5× normal alongside the move — attention-crowded names tend to reverse over the following weeks.

← All broader-coverage names · Curated names → · Open the interactive screener →

Data as of 2026-08-08 (end-of-day). How grades are computed →